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The D2 andD3 dopamine receptor subtypes are structurally homologous and couple to the same signal transduction pathways. Nevertheless, their
evolutionary conservation suggests that the two subtypes might exhibit unique signaling characteristics. We previously determined that D3 but not
D2S dopamine receptor exhibits a tolerance property in which the D3 receptor-activated G-protein coupled inward rectifier potassium currents
progressively decreases upon repeated agonist stimulation. In this paper, using AtT-20 neuroendocrine cells stably expressing either human D3 or
D2S receptor, we show that the tolerance property is also observed in the D3 receptor-adenylyl cyclase and D3 receptor-mitogen-activated protein
kinase signaling pathways. We have previously shown that the second cytoplasmic loop of D3 receptor is required for tolerance. Here, using site-
directed mutagenesis, we identified the specific amino acids in the D3 second cytoplasmic loop involved in the tolerance property. The results show
that substitution of a non-conserved cysteine residue at position 147 with positively-charged lysine or arginine residues abolishes tolerance.
Interestingly, the cysteine 147 residue is embedded in a putative phosphorylation site adjacent to two serine residues.Mutation of these serine residues
to alanine also attenuates tolerance. Taken together, these structural studies suggest a role for phosphorylation in D3 receptor tolerance property.
© 2007 Elsevier B.V. All rights reserved.Keywords: Desensitization; Potassium channels; Adenylyl cyclase; MAP kinase; Signaling; Dyskinesia1. Introduction
Dopamine receptors belong to the super family of seven-
transmembrane G-protein-coupled receptors [1,2] and are
classified based on sequence homology, pharmacology, and
signal transduction properties into D1-like and D2-like
dopamine receptor subtypes [3]. The D1-like receptors include
D1 and D5 receptor subtypes and the D2-like receptors include
D2, D3, and D4 receptor subtypes. D2 and D3 receptors
modulate various signal transduction pathways via associated
G-proteins [1]. Agonist-stimulation of D2 and D3 receptors
inhibits adenylyl cyclase and decreases cAMP production via
Gαi/o subunit [2]. Initial studies were not able to show an
effective coupling of D3 to adenylyl cyclase [4]; however,
subsequent studies showed that the D3 receptor specifically⁎ Corresponding author. Department of Pharmacology and Physiology,
UMDNJ-New Jersey Medical School, MSB, I-647, 185 South Orange Avenue,
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doi:10.1016/j.bbamcr.2007.06.007couples to adenylyl cyclase V isoform overexpressed in
heterologous expression systems [5]. In mammalian cell lines,
D2 and D3 receptors also couple to the mitogen-activated
protein kinase (MAPK) pathway [6,7].
In the AtT-20 neuroendocrine cells, we have previously
demonstrated that the stably-transfected human D3 receptor
robustly couples to natively-expressed, endogenous adenylyl
cyclase V [8] and GIRK channels [9,10]. By comparing the
coupling of D2S (the short isoform of D2) and D3 dopamine
receptors to endogenous GIRK channels in AtT-20 cells, we
have also demonstrated that the human D3, but not the D2S
dopamine receptor exhibits tolerance and slow response
termination properties [11]. The D3 receptor tolerance property
is defined as a progressive decrease in agonist-induced GIRK
response upon repeated agonist stimulation. The slow response
termination property of the D3 receptor describes the prolonged
delay in termination of agonist-induced GIRK response after the
removal of the agonist. Together the tolerance and slow response
termination properties distinguish D3 and D2 receptor signaling,
which could be potentially important for normal physiological
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tolerance property of the D3 receptor and determine if the
tolerance property is exhibited by other D3 receptor signal
transduction pathways. In addition, given that the second
cytoplasmic loop of D3 receptor is involved in the tolerance
property, we were interested in identifying the specific amino
acid residues in the second cytoplasmic loop that determine the
tolerance property.
In the present study we demonstrate that agonist-induced
tolerance of the D3 receptor is also exhibited in adenylyl cyclase
and MAPK signaling pathways. Our results show that
substitution of the non-conserved cysteine residue at position
147 with positively-charged amino acid residues abolishes D3
receptor tolerance property. Mutation of adjacent S145 and
S146 residues (present in a putative serine phosphorylation site)
also attenuates tolerance, suggesting a role for phosphorylation
in the D3 receptor tolerance property.
2. Materials and methods
2.1. Cell culture and transfection
AtT-20 mouse pituitary cells were grown in Ham's F10 medium with 5%
fetal bovine serum (FBS), 10% heat-inactivated horse serum, 2 mM glutamine
and 50 μg/ml gentamicin (Invitrogen, Carlsbad, CA). AtT-20 cells stably
expressing human D2S (AtT-D2S), D3 (AtT-D3) or Flag™-tagged D3 (AtT-
Flag™ D3) dopamine receptor subtypes were maintained in the above F10
culture media supplemented with 500 μg/ml G418 (Invitrogen). AtT-20 cells
stably expressing Flag™-tagged D3C147K construct were generated by
transfecting parental AtT-20 cells with the recombinant Flag™-tagged
D3C147K construct using DMRIE-C transfection reagent (Invitrogen, Carlsbad,
CA). Forty-eight hours post-transfection, the selection process was initiated by
treating transfected cells with 1 mg/ml of geneticin (G418; Invitrogen, Carlsbad,
CA). Selection medium was exchanged every 2–3 days, and the cells were
grown for 14 days. Selected clones resistant to G418 were assayed for the
expression of Flag™-tagged D3C147K receptor with a Flag™ antibody (Sigma,
St. Louis, MO) using Western blot analysis. We selected clones that expressed
the Flag™-tagged D3C147K receptor protein at the same level as the AtT-
Flag™ D3 cell line. The AtT-20 cell line expressing Flag™-tagged D3C147K
receptor (AtT-Flag™D3C147K) was also maintained in F10 culture media
supplemented with 500 μg/ml G418. Radioligand binding studies using [3H]
quinpirole showed that the Bmax values for the AtT-Flag™D3 and AtT-
Flag™D3C147K clonal cell lines used in this study were 1028±63 and 952±
43 fmol/mg, respectively. The binding affinity (KD) of quinpirole for the
Flag™ tagged D3 and Flag™ tagged D3C147K receptors were 4.89±0.38 nM
and 3.97±0.42 nM, respectively. We have previously reported that AtT-D2S
cell line has a Bmax value of 854±20 fmol/mg [8].
In some studies, parental AtT-20 cells were transiently-transfected with
1.0 μg of plasmid containing wild-type or mutant human D3 receptors and
0.2 μg of plasmid containing the enhanced green fluorescent cDNA (EGFP;
Clontech, Palo Alto, CA) per well, using the DMRIE-C reagent (Invitrogen).
EGFP plasmid was used as a marker to identify transfected cells. For
electrophysiological characterization, AtT-20 cells were plated onto glass
coverslips coated with 40 μg/ml poly L-lysine (Sigma, St. Louis, MO) in a 12-
well plate. All electrophysiological characterizations of transfected fluorescent
cells were carried out 36–48 h post-transfection.
2.2. Construction of mutant receptors
The various human D3 dopamine receptor mutants were generated using a
PCR-based subcloning strategy that utilized one primer that contained the
required mutations and a flanking primer. The primer pair generated mutation
containing amplicons with unique restriction sites. These restriction sites were
used to replace the region in the wild type D3 receptor with the mutationcontaining amplicon. All mutant human D3 receptor plasmids were initially
characterized by restriction enzyme analysis and finally by DNA sequencing.
Generation and characterization of the Flag™ tagged human D3 receptor has
been previously described [11]. The Flag™ tag was introduced at the N-terminal
of the human D3 receptor [11]. The Flag™ tagged human D3C147Kmutant was
generated by subcloning and substituting a restriction fragment containing the
C147K mutation into the wild type Flag™ tagged human D3 receptor. All
plasmids encoding the wild type and mutant receptors were purified on two
sequential cesium chloride density gradients. Before transfecting, all plasmids
containing the mutations were subjected to DNA sequencing. The sequencing
results showed that no extraneous mutations were introduced in these plasmids.
All wild type and mutant receptor cDNA were subcloned into the pcDNA3.0
mammalian expression vector (Invitrogen).
2.3. Electrophysiology, drugs, and solutions
Agonist-activated currents were measured by the whole-cell patch clamp
technique as described before [11]. Briefly, cells were held at −65 mV and
inward K+ currents induced by drug solutions were measured. The external
solution (SES) used for K+ current measurements was, in mM: 145 NaCl, 5 KCl,
2 CaCl2, 1 MgCl2, 10 HEPES [pH 7.4], and 10 glucose and the pipette solution
contained in mM: 130 K-Aspartate, 20 NaCl, 1 MgCl2, 10 HEPES [pH 7.4],
10 glucose, 0.1 GTP, 5 Mg-ATP, and 1 EGTA. To enhance inwardly rectifying
K+ currents, controls and drug exposures were performed in solutions with
elevated extracellular [K+] (30 mM) by substitution for Na+. (−) Quinpirole
(Sigma, St. Louis, MO, USA) was dissolved in water and used at indicated
concentrations. A 10-mM stock of dopamine (Sigma) was freshly dissolved in
100 mM ascorbic acid and used at a final concentration of 100 nM. Drug
solutions were delivered to cells via a multi-barreled micropipette array. The
current responses were normalized to the cell capacitance, to account for
variation in cell size.
2.4. Data analyses
Currents were measured using an Axopatch 200B amplifier (Axon
Instruments, Union City, CA, USA) and sampled through a Digidata 1322A
interface (Axon Instruments, Union City, CA, USA) using the pClamp 8.0
software (Axon Instruments, Union City, CA, USA). Data files were imported
into SigmaPlot (SPSS Inc., Chicago, IL, USA) for analysis and display.
SigmaPlot was also used to perform two-tailed Student's t-test. Analysis of
variance (ANOVA) and the Holm's multiple pair-wise comparison tests were
performed with Primer of Biostatistics software (Version 5.0, McGraw-Hill,
New York, NY, USA). Data were considered statistically different when
probability was b0.05.
2.5. Radioligand binding assay
We have previously described the procedure for membrane isolation and
radioligand binding assay [8]. AtT20 clonal lines expressing human Flag™
tagged D3 and D3C147K receptors were grown in six 100-mm tissue culture
plates to approximately 80% confluence. In experiments that evaluated
persistent agonist binding, AtT-Flag™ D3 cells were pretreated with either
SES or 100 nM non-radio labeled quinpirole for 1 min. Both control and
pretreated cells were thoroughly washed several times in SES for a total of
20 min. The wash procedure included three quick rinses with 10 ml of SES,
followed by four rinses with 10 ml SES. Each of the four rinses was for 5 min at
room temperature (25 °C). To isolate membranes, cells were scraped in ice-cold
Harvest Buffer (HB: 10 mM Tris–HCl [pH 7.4], 5 mM MgSO4) and lysed with
10 strokes of a Dounce A homogenizer. The nuclei were pelleted at 1000×g for
5 min and the supernatant spun at 45,000×g for 20 min to pellet the membrane
fraction. The membrane pellet was washed by resuspending the pellet in HB and
repeating the high-speed centrifugation. All centrifugation steps were done at
4 °C. The washed membrane pellet was resuspended in Binding Buffer (BB:
50 mM Tris–HCl [pH 7.4], 120 mM NMDG, 5 mM KCl, 4 mM MgCl2, 1 mM
EDTA) and stored at −70 °C.
Binding assays were performed as described previously [8]. The frozen
membrane pellets were thawed on ice and resuspended using three short pulses
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concentrations of [3H]quinpirole (Specific activity-48.9 Ci/mmol; Perkin Elmer,
Boston, MA, USA) in Binding Buffer (BB) for 60 min at room temperature
(25 °C). Eticlopride (1 μM; Sigma, St. Louis, MO, USA) was used to define
non-specific binding. Following incubation, the reactions were rapidly filtered
through Whatman GF/B filters that were pretreated with 0.3% polyethylenimine
(Sigma, St. Louis, MO, USA) and washed three times with ice-cold wash buffer
(50 mM Tris–HCl, pH 7.4) using a cell harvester (Inotech Biosystems,
Rockville, MD, USA). The filters were dried overnight, incubated in
CytoScint™-ES scintillation cocktail (MP Biomedicals, Irvine, CA, USA)
and radioactivity determined using a Beckman liquid scintillation counter
(LS5000TA) with a counting efficiency of 59.7%. The binding assays were done
in triplicates and each assay repeated two independent times. The data were
analyzed using non-linear regression and the data points were fit with a one-site,
two-parameter equation using Sigma Plot (SPSS Inc., Chicago, IL, USA).
2.6. Cyclic AMP assay
Cyclic AMP (cAMP) levels of pretreated and non-pretreated samples were
measured using the cAMP Biotrak Enzymeimmunoassay (EIA) System (GE
Healthcare, Piscataway, NJ). AtT-D2S, AtT-Flag™D3 and AtT-Flag™D3C147K
stably expressing human D2S, Flag™-tagged D3 and Flag™-tagged D3 C147K
dopamine receptors, respectively, were plated in 12-well plates and cultured for
48 h. To minimize variations due to differences in cell plating density and growth
rate, we used two wells for each variable. The pretreated samples received 100 nM
quinpirole, while control samples without pretreatment received SES for 1 min.
Both control and pretreated cells were thoroughly washed several times in SES for
a total of 20min. Thewash procedure included three quick rinseswith 1ml of SES,
followed by four rinses with 1 ml SES. Each of the four rinses was for 5 min at
room temperature (25 °C). Following the washes, the cells were treated for 15 min
at 37 °C with 10 μM forskolin+300 μM IBMX or 10 μM Forskolin+300 μM
IBMX+100 nM quinpirole. Cells were lysed using the reagent provided in the kit.
Sample lysates from the two wells were pooled, diluted 4-fold and 0.1 ml
transferred into three independent wells of the 96-well EIA plate. The cAMP levels
were measured by following the recommendations of the kit manufacturer (GE
Healthcare). The final absorbance valuesweremeasured at 450 nmon aModel 680
Microplate Reader (Bio-Rad, Hercules, CA). The amount of cAMP in each well
was determined by comparing the absorbance values of the treated variables with a
series of standards provided with the kit. For each experiment, the standards were
assayed in parallel and used to generate a standard curve with a linear detection
range that spanned 13–3200 femtomol/well. The 4-fold dilution of the treated
samples ensured that the cAMP levels were within the linear range of the cAMP
assay kit. The cAMP levels in each treated sample were assayed in triplicate and
adjusted to the total protein concentration in each sample. The entire experiment
was repeated three independent times.
2.7. Detection of ERK phosphorylation
For the MAPK studies, AtT-D2S, AtT-Flag™ D3 and AtT-Flag™D3C147K
cell lines were grown in 6-well plates until 80–90% confluent. The cells were
incubated in Opti-MEM serum-free medium for 4 h prior to treatment. The cells
were then pretreated with 200 nM QP or SES for 1 min, followed by several
thorough SES washes for 20 min. Both control and pretreated cells were
thoroughly washed several times in SES for a total of 20 min. The wash
procedure included three quick rinses with 3 ml of SES, followed by four rinses
with 3 ml SES. Each of the four rinses was done for 5 min at room temperature
(25 °C). Subsequently, the cells were treated with 200 nM QP for 0, 2, or 5 min
and lysed using a lysis reagent (62.5 mM Tris–HCl [pH 6.8], 10 mM sodium
fluoride, 1 mM phenylmethylsulphonyl fluoride (PMSF), 1 mM sodium
orthovanadate, 1 mM EDTA, 1 mM EGTA, 200 mM DTT, 1 μg/ml phosphatase
inhibitor (Sigma), 1 μg/ml protease inhibitor cocktail (Sigma), 2% SDS, 0.5%
TritonX-100, and 10% glycerol). Following centrifugal clarification, the
supernatants were boiled for 3 min at 95 °C and 30 μl of cell lysate loaded on
a 10% SDS polyacrylamide gel. The separated proteins were electroblotted onto
nitrocellulose membrane and blocked in 5% nonfat milk. Activated (phos-
phorylated) ERK1 and ERK2 were first detected using monoclonal phospho-
p44/p42MAPK antibody (1:1000 dilution; Cell Signaling Technology, Danvers,
MA). Following the detection of phosphorylated proteins, the membrane wasstripped and reprobed to detect total ERK1/ERK2 proteins. Total ERK proteins
were detected using a polyclonal antibody (1:1000 dilution; Cell Signaling
Technology) overnight at 4 °C. Horseradish peroxidase conjugated anti-mouse
or anti-rabbit secondary antibodies (1:2,000, Pierce Biochemicals, Rockford, IL)
and SuperSignal® West Dura extended duration substrate chemiluminescence
detection kit (Pierce Biochemicals, Rockford, IL) were used to detect the
signals. Immunoblots shown are from representative experiments that were
repeated at least three independent times with comparable results.
3. Results
3.1. D3 receptor exhibits tolerance property in three different
signaling pathways
In AtT-20 neuroendocrine cells heterologously expressed
human D3 and D2S receptors couple to endogenous GIRK
channels [9,10] and endogenous adenylyl cyclase V [8]. We
have previously shown that non-transfected AtT-20 cells do not
express endogenous dopamine receptors and do not induce
GIRK currents when treated with quinpirole [8, 9]. We have
also shown that GIRK responses elicited by activating D3, but
not D2S, dopamine receptors with synthetic agonist, quinpirole,
exhibits tolerance [11]. To determine if the native dopamine
receptor ligand also induces D3 receptor tolerance, we
measured the GIRK response in AtT-20 cells stably expressing
the human D3 receptor after multiple treatments of 100 nM
dopamine. The results in Fig. 1A show that in AtT-20 cells
stably expressing human D2S dopamine receptors (AtT-D2S),
dopamine does not cause tolerance, inducing multiple responses
of equal magnitude. In contrast, in AtT-20 cells stably
expressing human D3 dopamine receptors (AtT-D3), dopamine
induces tolerance with the magnitude of GIRK response
progressively decreasing upon repeated dopamine application
(Fig. 1B). Cumulative data suggest that dopamine, like
quinpirole induces significant tolerance in D3 but not D2S
dopamine receptor (Fig. 1C). The second D3 receptor-induced
GIRK response elicited by dopamine was 60% less than the first
(Fig. 1C). Given the equivalent effects of dopamine and
quinpirole, in subsequent experiments we exclusively used the
D2/D3 agonist quinpirole.
We next determined if the second D3 receptor-induced GIRK
response could be increased by treating the cells with a higher
concentration of agonist. We treated the AtT-D3 cell with
100 nM quinpirole, elicited the first GIRK response, washed out
the agonist till the current returned to baseline and then treated
the cell a second time with different concentrations of quinpirole
(10, 30, 100, 300 and 1000 nM). The ratio of the second GIRK
response to first GIRK response in this experiment was found to
be 0.31±0.08 (10 nM, n=4 cells); 0.28±0.05 (30 nM, n=4
cells); 0.39±0.033 (100 nM, n=9 cells); 0.41±0.03 (300 nM,
n=6 cells); and 0.40±0.06 (1000 nM, n=4 cells). These results
suggest that the D3 receptor tolerance induced by the initial
100 nM quinpirole treatment is not overcome by treating the
cells, a second time, with a higher concentration of quinpirole.
To determine the duration of tolerance and to simulate
treatment conditions used in the biochemical experiments
described later, we pretreated the AtT-D3 cells with 1 ml SES
or 100 nM quinpirole for 1 min and washed the cells for 20 min
Fig. 1. Dopamine and quinpirole induce equivalent tolerance. Representative current traces from whole cell voltage clamp recording of AtT-D2S (A) or AtT-D3 (B)
cell. The cell was held at −65 mV and inward currents were elicited by multiple 1 min applications of 100 nM dopamine (black rectangles). (C) Cumulative data
showing the mean (±SE) ratio of second to first inward GIRK currents (tolerance) induced by either 100 nM quinpirole (QP, black bar) or 100 nM dopamine (Dop,
hatched bar). The tolerance induced by both quinpirole and dopamine in AtT-D3 cells is significantly different from AtT-D2S cells (*Pb0.001, n=8 cells, Student's
t-test). (D) Cumulative data showing the mean (±SE) GIRK response elicited by 100 nM quinpirole in AtT-D3 cells that were pretreated for 1 min with either SES or
100 nM quinpirole and washed for 20 min as described in Materials and methods. The acute GIRK currents were normalized to cell capacitance. AtT-D3 cells
pretreated with 100 nM quinpirole elicited a significantly smaller GIRK response compared to those pretreated with SES (*Pb0.001, n=9 cells, Student's t-test).
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whole cell voltage clamp recording was performed to measure
100 nM quinpirole-induced GIRK currents. The results in Fig.
1D show that the AtT-D3 cells pretreated with 100 nM
quinpirole elicited a GIRK response (2.74±0.2 pA/pF) that
was 58% less compared to cells pretreated with control SES
(6.61±0.54 pA/pF). These results suggest that the D3 receptor-
GIRK channel signaling pathway maintains its tolerance
property even after a 20-min wash period.
In AtT-D2S and AtT-Flag™ D3 cells, following stimulation
with 100 nM quinpirole, forskolin-induced cAMP level is
inhibited approximately 50% (103.5±6.8 to 51.6±2.0 pmol/
mg) and 59% (86.3±2.5 to 35.7±2.5 pmol/mg), respectively
(Fig. 2A). To determine if the D3 receptor-adenylyl cyclase
signaling pathway exhibits the tolerance property, we pretreated
cells with either control SES or 100 nM quinpirole for 1 min.
Following the extensive wash procedure described in Materials
and methods, all cells were treated with 10 μM forskolin and
300 μM IBMX in the presence or absence of 100 nM
quinpirole. Our results indicate that in AtT-Flag™ D3 cells
pretreated for 1 min with 100 nM quinpirole, the ability of the
second quinpirole treatment to inhibit forskolin-induced cAMPlevels is significantly attenuated. Fig. 2A shows that in contrast
to the 59% inhibition of forskolin-induced cAMP levels in
control AtT-Flag™ D3 cells (86.3±2.5 to 35.7±2.5 pmol/mg),
cells pretreated with 100 nM quinpirole showed only 28%
inhibition (81.2±3.3 to 58.6±3.9 pmol/mg). The ability of D2S
receptors to inhibit forskolin-induced cAMP levels was not
affected by the 100-nM quinpirole pretreatment. The ratio of
inhibitory response elicited in cells pretreated with quinpirole
divided by the inhibitory response elicited in cells pretreated
with control SES, gives a measure of tolerance. Fig. 2B shows
that D3, but not D2S, receptor exhibits tolerance in the adenylyl
cyclase signaling pathway.
Previous studies have shown that stimulation of D2 and D3
dopamine receptors induces activation of the MAPK pathway,
with the maximum phosphorylation of p44 (ERK1) and p42
(ERK2) occurring at 5 min [6,7]. Consistent with these
observations, we show that quinpirole treatment of AtT-D2S
and AtT-Flag™ D3 cells induces robust phosphorylation of
ERK1/ERK2 at 5 min (Fig. 3). To determine if the tolerance
property of the D3 receptor is exhibited in the MAPK pathway
we pretreated AtT-D2S or AtT-Flag™ D3 cells with either
control SES or 200 nM quinpirole for 1 min. Following the
Fig. 2. Tolerance is exhibited in the D3-adenylyl cyclase signaling pathway. (A) Cumulative data showing the mean intracellular cAMP levels in AtT-D2S and
AtT-Flag™D3 cells treated with 10 μM forskolin and 300 μM IBMX in the absence (F) or presence of 100 nM quinpirole (QF). Before treating the cells with F or QF,
the AtT-D2S and AtT-Flag™ D3 cells were pretreated for 1 min with either control SES (−) or 100 nM quinpirole (+) and washed for 20 min as described in Materials
and methods. Under all conditions, in both cell lines, quinpirole significantly reduced the forskolin-induced increase in intracellular cAMP levels (Pb0.001,
Student's t-test). (B) However, mean tolerance, defined as the quinpirole-induced inhibition in cells that were pretreated with 100 nM quinpirole divided by
quinpirole-induced inhibition in cells pretreated with control SES was significantly different between AtT-Flag™ D3 cells and AtT-D2S cells (*Pb0.001, Student's
t-test). AtT-Flag™ D3 cells pretreated with 100 nM quinpirole showed significantly reduced adenylyl cyclase inhibition upon second quinpirole treatment
compared to cells pretreated with SES. The experiments were repeated three independent times.
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all cells were treated with or without 200 nM quinpirole for 2 and
5 min to induce ERK1/ERK2 phosphorylation. Fig. 3A shows
that in AtT-D2S cells, phosphorylation of ERK1/ERK2 induced
by the second quinpirole application was not significantlyFig. 3. Tolerance is exhibited in the D3-MAPK signaling pathway. Representative W
ERK2 (Phospho-p44/p42MAPK) proteins in AtT-D2S (A) and AtT-Flag™D3 (B) ce
washed and subsequently treated with control (0′) or 200 nM quinpirole for 2 and
normalized to the levels of total MAPK proteins. The experiments were repeated thaffected by the quinpirole pretreatment. In contrast, in AtT-
Flag™ D3 cells, pretreatment significantly reduced the ERK1/
ERK2 phosphorylation induced by the second quinpirole
application (Fig. 3B). Measurement of the ratio of ERK
phosphorylation induced with and without pretreatment showestern blots showing 200 nM quinpirole-induced phosphorylation of ERK1 and
lls. Cells were pretreated for 1 min with either control SES or 200 nM quinpirole,
5 min. The levels of quinpirole-induced phosphorylated MAPK proteins were
ree independent times.
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ance compared to D2S receptors (ratio=0.80±0.08).
Taken together, the results in Figs. 1–3 clearly demonstrate
that the tolerance property of D3 receptor is exhibited by three
different signal transduction pathways, and strongly suggest
that tolerance is an intrinsic property of the D3 receptor that is
not limited to a particular signaling pathway.
3.2. D3 receptor tolerance is not mediated by persistent agonist
binding
Despite the extensive washes, the tolerance property of D3
receptor could be due to persistent agonist binding. To directly
determine this, we performed radioligand binding assays with
[3H]quinpirole on AtT-Flag™ D3 cells that were pretreated for
1 min with control SES or 100 nM non-radiolabelled quinpirole
and washed extensively as described inMaterials andmethods. If
the non-radiolabelled quinpirole was persistently bound to the D3
receptor, the ability of the [3H]quinpirole to bind to the cells
would be reduced and reflected in the Bmax and KD values. The
results in Fig. 4 show that neitherBmax norKD values were altered
by the 100-nM quinpirole pretreatment (Bmax=1028±63 and
1112±98 fmol/mg; KD=4.89±0.38 nM and 4.11±0.27 nM for
control and pretreated cells, respectively). These results suggest
that persistent binding of quinpirole to the D3 receptor does not
induce tolerance. This is also consistent with the observations that
in the three signaling pathways studied, the functional response
recovers to the baseline following agonist washout.
3.3. Cysteine 147 in the second loop of the D3 receptor is
involved in tolerance
We have previously determined that the second cytoplasmic
loop of the D3 dopamine receptor is required for the tolerance
property [11]. Since D2S dopamine receptors do not exhibit
tolerance (Figs. 1–3 and [11]), we hypothesized that theFig. 4. Tolerance is not mediated by persistent quinpirole binding. Specific
[3H]quinpirole binding to AtT-Flag™ D3 cells that were pretreated for 1 min with
either SES (grey upright triangle) or 100 nM non-labeled quinpirole (black filled
circle) andwashed for 20min as described inMaterials andmethods. The saturation
binding curves were obtained by fitting the data to a one-site model as described in
Materials and methods and represent the mean of two independent experiments.tolerance property of D3 receptor is mediated by amino acid
residues in the second intracellular loop that are different from
the D2S receptor (Fig. 5A). The D2S second cytoplasmic loop is
also two amino acids shorter than the D3 receptor's loop,
suggesting an alternate hypothesis that the difference in length of
the second cytoplasmic loop between D2S and D3 receptor
might be important for tolerance. To test the first hypothesis, we
generated mutant D3 receptors in which the non-conserved
amino acid residues in the second intracellular loop of the D3
receptor were mutated to the corresponding amino acid residues
in the D2S receptor (D3GQ143RY and D3C147K). To test
the second hypothesis, we generated a D3 receptor mutant
(D3QHΔ) in which we deleted Q139 and H140 residues present
in the second cytoplasmic loop of D3 receptor. As a control, to
evaluate the functional importance of the Q139 and H140
residues, we also generated mutant D3 receptors in which either
one (D3H140G) or both the Q139 and H140 residues were
mutated to glycines (D3QH139GG).
The mutant and wild type D3 receptor expressing plasmids
were transiently-transfected individually into AtT-20 cells. We
assessed the function of mutant and wild type D3 receptors by
measuring the quinpirole-induced GIRK responses using
whole-cell, voltage-clamp recording method. All D3 receptor
mutants were functional and induced a robust acute GIRK
response (Table 1). The mean acute GIRK response induced by
the wild-type D3 receptor and the mutant D3 receptors were
similar with the exception of the QHΔ and QH139GG mutants.
These mutant receptors showed a significantly reduced acute
response than the wild-type D3 receptor (Table 1). To assess the
tolerance property of the mutated D3 receptors, we determined
the ratio of 2nd to 1st quinpirole-induced GIRK responses. The
tolerance exhibited by the D3 receptor mutants was compared to
the D2S and D3 wild-type receptors as well as the D3D2SII
chimera (in which the entire second cytoplasmic loop of D3
receptor is replaced with the D2S receptor second cytoplasmic
loop;). The cumulative data in Fig. 5B show that of all the
mutants only D3C147K abolished the tolerance, exhibiting a
mean tolerance value that was similar to D2S and D3D2SII
chimeric receptors. These results strongly suggest that the
cysteine 147 residue is centrally involved in the D3 receptor
tolerance property. The results also suggest that a difference in
the length of the second cytoplasmic loop between D2S and D3
receptor does not affect the tolerance property.
The loss of tolerance observed in the D3C147Kmutant could
be due to a decrease in receptor binding affinity for quinpirole or
due to altered functional dose response. To address these issues,
we compared the receptor binding affinity of D3 and D3C147K
mutants using the clonal cell lines stably expressing the Flag™
tagged D3 receptor or the Flag™ tagged D3C147K mutant
receptor. The binding affinity (KD) of quinpirole for the Flag™
tagged D3 and Flag™ tagged D3C147K receptors were 4.89±
0.38 nM and 3.97±0.42 nM, respectively. This result suggested
that the loss of tolerance in the C147K mutant was not due to a
decrease in binding affinity. To further confirm these results we
performed a functional quinpirole dose response study comparing
the ability of the Flag™ tagged D3 and D3C147K receptor to
activate GIRK channels. A change in receptor binding affinity
Table 1
Acute quinpirole-induced GIRK responses of wild type D2S, D3 and second
cytoplasmic loop mutant D3 receptors
Name Mean quinpirole-induced current
density (±SE)
(pA/pF) N
D3 6.1 (±0.50) 12
D3D2SII 9.1 (±0.77) a 13
D3QH ▵ 4.1 (±0.45) b 8
D3QH139GG 3.7 (±0.59) b 11
D3H140G 5.1 (±0.64) 10
D3GQ143RY 5.9 (±0.87) 11
D3C147K 6.3 (±0.60) 9
Wild type and mutant D3 receptor constructs were transiently-transfected in to
AtT-20 cells. Forty-eight hours post-transfection, whole cell voltage clamp
recording was performed on individual cells. Cells were stimulated with 100 nM
quinpirole and acute inward GIRK currents were measured and divided by cell
capacitance to obtain current density (pA/pF). N indicates the number of cells
tested.
a Significantly greater than the current density elicited with wild type D3
receptors (Pb0.005, Student's t-test).
b Significantly less than the current density elicited with wild type D3
receptors (Pb0.01, Student's t-test).
Fig. 6. Mutation of C147 residue in D3 receptor does not alter the quinpirole
dose response curve. Dose-dependent increase in quinpirole-induced GIRK
currents in AtT-Flag™ D3 (grey circle) and AtT-Flag™ D3C147K (black
upright triangle) cells are similar. For each quinpirole concentration, we tested 5
and 6 cells for AtT-Flag™D3 and AtT-Flag™D3C147K cell lines, respectively.
The data points were fit using a Hill 4 parameter equation.
Fig. 5. Mutation of the C147 residue in D3 receptor abolishes tolerance.
(A) Alignment of the second cytoplasmic loop of human D3 and D2S
dopamine receptor shows the positions of non-conserved amino acids. The
arrows indicate the amino acid residues that were mutated or deleted in this
study. (B) Cumulative data showing the mean ratio of 2nd to 1st quinpirole (QP)-
induced GIRK response in AtT-20 cells transiently-transfected with wild type
D3, D2S, chimeric D3D2SII or various second cytoplasmic loop mutant D3
receptors. The GIRK responses were determined by measuring the inward
currents elicited at −65 mV by 100 nM quinpirole in whole cell voltage clamp
recording mode. The tolerance exhibited by D2S, D3D2SII and D3C147K
receptors was significantly different from wild type D3 as well as the other
second loop mutant receptors (*Pb0.01, ANOVA, post-hoc Holm's test).
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response curve. The results in Fig. 6 show that the wild type D3
and mutant D3C147K receptors have a similar dose response
curve. The EC50 values for quinpirole-induced GIRK channel
activation were 20.9±6.1 nM and 15.2±4.7 nM for Flag™
tagged D3 and Flag™ tagged D3C147K receptors, respectively.
Together these results suggest that loss of tolerance in the
D3C147K mutant is not due to changes in binding affinity.
To determine if the C147 residue of D3 receptor is also
involved in the tolerance exhibited in the adenylyl cyclase and
MAPK signaling pathways, we compared the ability of Flag™-
tagged D3C147K to elicit multiple quinpirole-induced adenylyl
cyclase inhibitory responses and ERK phosphorylation. Com-
parison of tolerance elicited in AtT-D2S, AtT-Flag™ D3 and
AtT-Flag™ D3C147K cell lines shows that the tolerance
property of D3C147K mutant receptor is significantly different
from the D3 receptor and similar to the D2S receptor in both the
adenylyl cyclase (Fig. 7A) and MAPK (Fig. 7B) signaling
pathways. Taken together these results demonstrate that
substitution of a single non-conserved cysteine residue at
position 147 of D3 receptor with the corresponding lysine
residue from D2S dopamine receptor abolishes the tolerance
property in all three signaling pathways.3.4. Positively charged amino acids at position 147 abolishes
the tolerance property
The lack of tolerance exhibited by the D3C147K mutant
suggests that intrinsic characteristics of the cysteine residue in
D3 receptor might contribute to the tolerance property.
Alternatively, the lack of tolerance could be attributed to
intrinsic characteristic (such as charge or size) of the introduced
lysine residue. To distinguish between these hypotheses, we
generated several D3 receptor mutants in which the C147 amino
acid residue was mutated to alanine (D3C147A), serine
(D3C147S), glutamate (D3C147E) and arginine (D3C147R).
Mutation of cysteine to alanine or serine introduces small, non-
polar or nucleophilic amino acid residues at position 147 and
Fig. 7. Mutation of the C147 residue in D3 receptor abolishes tolerance property exhibited in D3-adenylyl cyclase and D3-MAPK signaling pathways. (A) Cumulative
data comparing the mean tolerance of adenylyl cyclase inhibition in AtT-D2S, AtT-Flag™ D3 and AtT-Flag™ D3C147K cells. Tolerance was determined by dividing
the 100-nM quinpirole-induced percent inhibition of forskolin-elevated cAMP levels in cells pretreated with 100 nM quinpirole by the 100-nM quinpirole-induced
percent inhibition of forskolin-elevated cAMP levels in cells pretreated with control SES. The AtT-Flag™ D3 cells exhibit significantly reduced response following
quinpirole pretreatment compared to both AtT-D2S and AtT-Flag™ D3C147K cells (*Pb0.001, ANOVA, post-hoc Holm's test). (B) Cumulative data comparing the
mean tolerance of MAPK activation in AtT-D2S, AtT-Flag™ D3 and AtT-Flag™ D3C147K cells. Tolerance was determined by dividing the 200-nM quinpirole-
induced phosphorylation of ERK1/2 at 5 min in cells pretreated with 200 nM quinpirole by the 200-nM quinpirole-induced phosphorylation of ERK1/2 at 5 min in
cells pretreated with control SES. The AtT-Flag™ D3 cells exhibits significantly reduced response following quinpirole pretreatment compared to both AtT-D2S and
AtT-Flag™ D3C147K cells (*Pb0.05, ANOVA, post-hoc Holm's test). The inset shows a representative Western blot showing 200 nM quinpirole-induced
phosphorylation of ERK1 and ERK2 (Phospho-p44/p42 MAPK) proteins in AtT-Flag™ D3C147K cells. Cells were pretreated for 1 min with either control SES or
200 nM quinpirole, washed and subsequently treated with control (0′) or 200 nM quinpirole for 5 min. The levels of quinpirole-induced phosphorylated MAPK
proteins were normalized to the levels of total MAPK proteins. The experiments were repeated three independent times.
Table 2
Acute quinpirole-induced GIRK responses of wild type D3 and C147 mutant D3
receptors
Name Mean quinpirole-induced current
density (±SE)
(pA/pF) N
D3 6.1 (±0.50) 12
D3C147K 6.3 (±0.60) 9
D3C147A 5.7 (±0.79) 9
D3C147S 5.8 (±0.85) 11
D3C147E 3.7 (±0.54) a 7
D3C147R 6.6 (±0.75) 8
Wild type and mutant D3 receptor constructs were transiently-transfected in to
AtT-20 cells. Forty-eight hours post-transfection, whole cell voltage clamp
recording was performed on individual cells. Cells were stimulated with 100 nM
quinpirole and acute inward GIRK currents were measured and divided by cell
capacitance to obtain current density (pA/pF). N indicates the number of cells
tested.
a Significantly less than the current density elicited with wild type D3
receptors (Pb0.01, Student's t-test).
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residue are important for tolerance. Mutation of cysteine to
arginine or glutamate introduces positive and negative charges,
respectively, at position 147 and would directly determine if
charge or size of the lysine residue is responsible for abolishing
tolerance.
The mutants and wild type D3 receptors were transiently-
transfected individually into AtT-20 cells and the coupling of
the receptors to endogenous GIRK channels was assessed using
whole cell voltage clamp recording. The results in Table 2 show
that all mutants were functional and elicited robust quinpirole-
induced GIRK responses. However, comparison of mean acute
quinpirole-induced GIRK responses showed that the D3C147E
mutant elicited a significantly reduced GIRK response com-
pared to wild type D3 receptors and other mutants (Table 2).
Assessment of tolerance property measured by the ratio of
second and first quinpirole-induced GIRK response showed
that while D3C147A, D3C147S and D3C147E exhibited
tolerance, the D3C147R mutant like the D3C147K mutant
did not show tolerance (Fig. 8). These results strongly suggest
that the intrinsic properties of the cysteine residue at position
147 do not contribute to the D3 receptor tolerance property.
Rather, introduction of a positive charge (either lysine or
arginine) at this position abolishes the tolerance property of the
D3 receptor. Furthermore, a negative charge at position 147 is
inhibitory and decreases the acute response induced by D3
receptor activation.3.5. Mutation of a putative serine phosphorylation site flanking
the C147 residue attenuates D3 receptor tolerance property
The results in Fig. 8 suggested that charged amino acid
residues at position 147 modulate the tolerance property.
Interestingly, the C147 residue is embedded in a putative
phosphorylation site adjacent to serine residues (Fig. 9A). The
Fig. 8. Positively charged residues at position 147 abolish tolerance. (A) Representative current traces from whole cell voltage clamp recordings of AtT-20 cells
transiently transfected with D3C147K (A), D3C147S (B) and D3C147R (C) mutants. The cells were held at −65 mV and inward currents were elicited by multiple
1 min applications of 100 nM quinpirole (black rectangles). (D) Cumulative data showing the mean ratio of 2nd to 1st quinpirole (QP)-induced GIRK response in AtT-
20 cells transiently-transfected with wild type D3, D2S, chimeric D3D2SII or various second cytoplasmic loop mutant D3 receptors. The GIRK responses were
determined by measuring the inward currents elicited at −65 mV by 100 nM quinpirole in whole cell voltage clamp recording mode. The tolerance exhibited by D2S,
D3D2SII, D3C147K and D3C147R mutant receptors was significantly different from wild type D3 as well as the other second loop mutant receptors (*Pb0.01,
ANOVA, post-hoc Holm's test).
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might be involved in D3 receptor tolerance property, and
introduction of a positively charged arginine or lysine residue
adjacent to phosphorylatable serine residues might neutralize
the effect of phosphorylation and abolish tolerance property. To
test this hypothesis we generated mutant D3 receptors in which
one (D3S146A) or both (D3SS145AA) serine residues were
mutated to alanine and assessed for function and tolerance
property. The acute quinpirole-induced GIRK response elicited
by the D3S146A (5.6±0.67 pA/pF) and D3SS145AA (4.93±
0.40 pA/pF) was similar to wild type D3 receptor (6.1±
0.46 pA/pF). However, compared to wild type D3 receptors,
both mutant receptors showed significantly attenuated toler-
ance (Fig. 9B). Interestingly, while the D3S146A and
D3S145AA receptors both showed significantly reduced
tolerance, unlike the D3C147K mutant, the tolerance was not
completely abolished. Taken together these results suggest that
the putative serine phosphorylation site in the second
cytoplasmic loop of D3 receptor is partially involved in the
tolerance property.4. Discussion
The signaling mechanisms and properties of D3 dopamine
receptor are not well understood. In this paper, we present novel
evidence that the human D3, but not D2S dopamine receptor
exhibits a tolerance property that affects three different signal
transduction pathways. Structure–function analysis using site-
directed mutagenesis of amino acid residues in the second
cytoplasmic loop identified specific amino acid residues in a
putative serine phosphorylation site involved in the tolerance
property. Along with our previous study [11], the results
presented in this paper strongly suggest that the tolerance
property functionally distinguishes the D3 and D2 dopamine
receptors. Our results show that the tolerance property is
induced by both the endogenous ligand dopamine as well as the
synthetic ligand quinpirole. It is an intrinsic property of the D3
receptor as it is observed in the D3-GIRK, D3-adenylyl cyclase
and D3-MAPK pathways. A previous study, using the Xenopus
oocyte heterologous expression system, has also reported the
D3 receptor tolerance property [12]. We have observed the D3
Fig. 9. Mutation of D3 receptor second cytoplasmic loop serine residues
attenuates tolerance property. (A) Alignment of the second cytoplasmic loop of
human D3 and D2S dopamine receptor shows the positions of non-conserved
amino acids and a putative serine phosphorylation site (shaded box). The arrows
indicate the serine residues that were mutated to alanine. (B) Cumulative data
showing the mean ratio of 2nd to 1st quinpirole (QP)-induced GIRK response in
AtT-20 cells transiently-transfected with wild type D3, D3C147K, D3SS145AA
or D3S146A mutant receptors. The GIRK response was determined by
measuring the inward currents elicited at −65 mV by 100 nM quinpirole in
whole cell voltage clamp recording mode. The tolerance exhibited by D3C147K,
D3SS145AA and D3S146A mutant receptors was significantly different from
wild type D3 (*Pb0.01, ANOVA, post-hoc Holm's test). In addition,
D3SS145AA and D3S146A mutant receptors was significantly different from
D3C147K mutant receptor (#Pb0.05, ANOVA, post-hoc Holm's test).
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receptors and GIRK channels are heterologously expressed in
AtT-20 or CHO cells (data not shown). The coupling of D3
receptor to signaling pathways in vivo has not been unambigu-
ously determined; therefore, to date there have been no direct
reports of D3 receptor tolerance property in vivo. Interestingly,
in a study that characterized coupling of D2-like dopamine
receptors to GIRK channels in primary neuronal cultures
derived from rat substantia nigra pars compacta, the authors
present data on two types of quinpirole-induced GIRK
responses—one that does not show tolerance and one that
shows robust tolerance [13]. We speculate that the former most
likely represented coupling of D2 receptors to GIRK channels
and the latter coupling of D3 receptors to GIRK channels.
Mutation or deletion of the Q139 and H140 residues reduced
the acute quinpirole-induced GIRK response; however, muta-
tion of H140 by itself had no effect. Together these results
suggest that the Q139 residue in the D3 receptor second
cytoplasmic loop is important for the function of the D3
receptor. At present, it is not known if the decreased function is
due to alterations in receptor binding affinity, G-protein
coupling or problems with protein folding, trafficking and cellsurface expression. Regardless of its effects on acute response,
the mutation of Q139 and/or H140 residues had no effect on D3
receptor tolerance. In contrast, the mutation of C147 residue to
lysine or arginine completely abolished the tolerance property
without affecting the acute response. Furthermore, the mutation
of C147 residue to lysine did not change agonist binding affinity
or shift the functional dose response curve. Interestingly, the
introduction of a negatively charged residue at C147 also
decreases the acute GIRK response without affecting tolerance.
Taken together these results suggest that the tolerance property
is not dependent on the magnitude of the acute D3 receptor-
induced response.
Most G-protein coupled receptors (GPCRs) undergo desen-
sitization in the continued presence of agonists [14]. In majority
of these receptors, the desensitization is mediated by receptor
phosphorylation, followed by internalization [14]. In the case of
the D3 receptor, in the continued presence of the agonist, the
receptor shows limited desensitization; however, once the
agonist is removed the receptor manifests the tolerance pro-
perty. While different from the desensitization property
described for most GPCRs, the tolerance property of D3
receptor could be explained by phosphorylation and inter-
nalization mechanisms; however, we have previously demon-
strated that the D3 receptor tolerance is not mediated by
receptor internalization [11]. The mutational studies presented
in this paper suggest that phosphorylation might be involved in
the D3 tolerance property. Mutation of S146 residue in the
second cytoplasmic loop of D3 receptor is sufficient to partly
attenuate the tolerance property (Fig. 9). In addition, mutation
of C147 residue to negatively charged glutamate residue
decreases D3 receptor function (Table 2), a result that could
be interpreted as the mutant receptor adopting a constitutive
inhibitory conformation akin to the tolerance state. Our working
hypothesis is that agonist binding to D3 receptor triggers a
signaling pathway that activates protein kinase(s) which
phosphorylates the S146 and potentially other residues. The
phosphorylation induces a conformation change that uncouples
the D3 receptor from its signaling pathway. We are currently
investigating the signaling mechanisms and kinases involved in
inducing D3 receptor tolerance.
There are several kinases that could potentially play a role in
D3 receptor tolerance. In the case of the closely-related D2
receptor, the agonist-induced homologous desensitization is
mediated by G-protein coupled receptor kinase (GRK) and β-
arrestins [15,16]. An increased coupling of D2 and D3 receptors
to their G proteins has been shown in GRK6 knockout mice,
which display enhanced locomotor responses when challenged
with dopamine agonists [17]. Thus, GRK-induced phosphor-
ylation mechanisms involved in desensitization of various
GPCRs [18,19] might also play a crucial role in agonist-induced
tolerance of the D3 receptor. However, given that the D3
receptor does not undergo agonist-induced internalization
during tolerance, any mechanism involving GRKs would be
different from the traditional role of these kinases.
D2 receptor also shows heterologous desensitizationwhen the
receptor is phosphorylated by protein kinase C (PKC) [20]. The
putative serine phosphorylation site in the second cytoplasmic
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property is a consensus PKC site that is conserved between D2
and D3 receptors (Fig. 9). Interestingly, in D2 receptors this site
in the second cytoplasmic loop is not phosphorylated by PKC
[20]. Given the difference in the tolerance property between D2
and D3 receptor, we speculate that this site might be
phosphorylated by PKC in the D3 receptor. We are currently
testing this hypothesis.
The differences in tolerance property between D2 and D3
receptors have important functional consequences. In the
context of GIRK channels and modulation of neuronal activity,
the tolerance property of D3 receptor results in the generation of
a firing pattern that is different from the D2 receptor. The D2
receptor hyperpolarizes the cell every time the receptors are
stimulated by dopamine or synthetic agonists; in contrast, D3
receptors hyperpolarize the cell during the first stimulation but
not during subsequent near-term stimulations [11]. Thus while
both D2 and D3 receptors couple to GIRK channels to hyper-
polarize the cell, the tolerance property of D3 receptor results in
the modulation of the functional output, generating a different
firing pattern. Increasing evidence indicates that the neuronal
oscillations and coordination of ensemble activity plays an
important role in the manifestation of motor behavior [21]. Thus
the differences in tolerance property of D3 and D2 receptors
might be important for normal physiological behavior. This role
might be disrupted in pathophysiological conditions when the
ratio of D3 and D2 receptor expression is altered during disease
states or following chronic treatment. In particular, during
levodopa-induced dyskinesia in Parkinson's disease the ratio of
D2 to D3 receptor expression is significantly altered due to
overexpression of D3 receptors in brain regions that predomi-
nantly express D2 receptors [22]. We propose that the alteration
of D2 and D3 receptor expression ratio and the associated
changes in the manifestation of tolerance property could sig-
nificantly change coordinated firing patterns, generating asyn-
chrony, and leading to the development of symptoms associated
with dyskinesia.
Numerous studies have suggested a role for D3 receptor in
stimulant drug induced behavioral sensitization [reviewed in
23]. It has been proposed that the loss of inhibitory D3
receptor function contributes to the development of behavioral
sensitization [23]. While the D3 receptor tolerance property
we describe develops rapidly, it might still be involved in the
development of behavioral sensitization. In particular, if there
are selective alterations in D3 receptor expression associated
with stimulant exposure, we speculate that this change in D3
receptor expression might alter the homeostasis vis-à-vis the
normal inhibitory response due to an over/under representa-
tion of the D3 receptor tolerance property. Thus, under-
standing the molecular mechanisms that cause tolerance might
help address pathological conditions such as dyskinesia and
addictive behaviors.
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